SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-096360
Filing Date
2024-08-13
Accepted
2024-08-13 16:42:15
Documents
5
Effectiveness Date
2024-08-13

Document Format Files

Seq Description Document Type Size
1 S-8 2024_s-8.htm S-8 154870
2 EX-5.1 atyr-ex5_1.htm EX-5.1 12338
3 EX-23.2 atyr-ex23_2.htm EX-23.2 3617
4 EX-FILING FEES atyr-exfiling_fees.htm EX-FILING FEES 26354
5 GRAPHIC img54294278_0.jpg GRAPHIC 33607
  Complete submission text file 0000950170-24-096360.txt   244697
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281525 | Film No.: 241202394
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)